About Element Biosciences
Element Biosciences is a company based in San Diego (United States) founded in 2017 by Michael Previte and Molly He.. Element Biosciences has raised $678.3 million across 7 funding rounds from investors including Fidelity Investments, Morgan Stanley and Samsung. Element Biosciences has completed 1 acquisition, including Element Biosciences. Element Biosciences offers products and services including AVITI24, Cloudbreak Sequencing Kits, Trinity Sequencing Kits, and ElemBio Cloud. Element Biosciences operates in a competitive market with competitors including 10X Genomics, DnaNudge, Laverock Therapeutics, Esya Labs and xMD, among others.
- Headquarter San Diego, United States
- Founders Michael Previte, Molly He
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$678.3 M (USD)
in 7 rounds
-
Latest Funding Round
$277 M (USD), Series D
Jul 11, 2024
-
Investors
Fidelity Investments
& 12 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Element Biosciences
Element Biosciences offers a comprehensive portfolio of products and services, including AVITI24, Cloudbreak Sequencing Kits, Trinity Sequencing Kits, and ElemBio Cloud. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Instrument for spatial co-detection of RNA, protein, and morphology in sequencing.
Kits for DNA and RNA sequencing applications in research.
Kits that simplify targeted sequencing workflows.
Software platform for managing sequencing data and analysis.
Unlock access to complete
Unlock access to complete
Software Development Team
24 people
Leadership Team
20 people
Sales and Marketing
18 people
Senior Team
13 people
Sr. Team
7 people
Product Management Team
7 people
Finance and Accounting
7 people
Operations Team
6 people
Unlock access to complete
Funding Insights of Element Biosciences
Element Biosciences has successfully raised a total of $678.3M across 7 strategic funding rounds. The most recent funding activity was a Series D round of $277 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series D — $277.0M
-
First Round
First Round
(01 Sep 2017)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2024 | Amount | Series D - Element Biosciences | Valuation | Wellington | |
| Jun, 2021 | Amount | Series C - Element Biosciences | Valuation | Janus Henderson Investors , Logos | |
| Jun, 2020 | Amount | Series B - Element Biosciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Element Biosciences
Element Biosciences has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, Morgan Stanley and Samsung. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage investment firm invests in healthcare and life sciences companies
|
Founded Year | Domain | Location | |
|
Multiple sectors are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Private equity fund focused on the biotechnology sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Element Biosciences
Element Biosciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Element Biosciences. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
DNA sequencing technologies are developed for microbiome and genomic applications.
|
2015 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Element Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Element Biosciences Comparisons
Competitors of Element Biosciences
Element Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, DnaNudge, Laverock Therapeutics, Esya Labs and xMD, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Instrument systems for genomic research and sequencing libraries are developed.
|
|
| domain | founded_year | HQ Location |
Lab-on-chip wearable systems for genetic diagnosis are provided.
|
|
| domain | founded_year | HQ Location |
Next-generation programmable cell therapies are developed using GEiGS technology.
|
|
| domain | founded_year | HQ Location |
Nanotechnology-based nucleic acid diagnostics are developed for early disease detection.
|
|
| domain | founded_year | HQ Location |
Laboratory instruments and consumables are developed for life science research.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Element Biosciences
Frequently Asked Questions about Element Biosciences
When was Element Biosciences founded?
Element Biosciences was founded in 2017.
Where is Element Biosciences located?
Element Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Element Biosciences?
Molly He is the current CEO of Element Biosciences. They have also founded this company.
Is Element Biosciences a funded company?
Element Biosciences is a funded company, having raised a total of $678.3M across 7 funding rounds to date. The company's 1st funding round was a Series B of $30M, raised on Sep 01, 2017.
What does Element Biosciences do?
Founded in 2017 and based in San Diego, United States, operations are centered in the biotechnology sector with a focus on genomics. Benchtop DNA sequencing technology is provided through the AVITI sequencer, which achieves high data quality via an enhanced contrast-to-noise ratio. Applications are targeted at research and diagnostic markets, supporting advancements in genetic analysis.
Who are the top competitors of Element Biosciences?
Element Biosciences's top competitors include 10X Genomics, Laverock Therapeutics and Esya Labs.
What products or services does Element Biosciences offer?
Element Biosciences offers AVITI24, Cloudbreak Sequencing Kits, Trinity Sequencing Kits, and ElemBio Cloud.
How many acquisitions has Element Biosciences made?
Element Biosciences has made 1 acquisition, including Element Biosciences.
Who are Element Biosciences's investors?
Element Biosciences has 13 investors. Key investors include Fidelity Investments, Morgan Stanley, Samsung, T. Rowe Price, and HHS.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.